Lmr Partners LLP Neurocrine Biosciences Inc Call Options Transaction History

Lmr Partners LLP

  • $10.9 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$114.58 - $153.15 $8.98 Million - $12 Million
-78,400 Reduced 37.02%
133,400 $15.4 Million
Q2 2024

Aug 14, 2024
BUY
$130.86 - $143.19 $6.58 Million - $7.2 Million
50,300 Added 31.15%
211,800 $29.2 Million
Q1 2024

May 15, 2024
BUY
$130.4 - $143.74 $21.1 Million - $23.2 Million
161,500 New
161,500 $22.3 Million

Others Institutions Holding NBIX

# of Institutions
629
Shares Held
94.2M
Call Options Held
692K
Put Options Held
406K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email